Methylation analysis as a diagnostic tool for sweat gland tumours classification with emphasis on the distinction between digital papillary adenocarcinoma and mimickers
Histopathology · 2025
DOI: 10.1111/his.15479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Pierre Sohier und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, AP-HP, Centre-Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Sweat Gland Neoplasms, DNA Methylation, Adenocarcinoma, Papillary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: illumina grant.
Abstract (Originalsprache)
Aims
Digital papillary adenocarcinoma (DPA) is a rare sweat gland carcinoma arising on acral sites. The main differential diagnosis included tubular adenoma, hidradenoma, poroid hidradenoma, and mixed tumours, distinction between DPA and these mimickers being crucial for therapeutic management. Recently, HPV42 was identified as the main oncogenic driver of most DPA. Controversially, a few sweat gland tumour cases diagnosed as “DPA” but lacking the HPV42 genome and harbouring instead a BRAF V600E mutation, a genetic hallmark of tubular adenomas, have been recently described. Methylation analysis is a powerful tool for tumour classification systems. In this context, the aim of the present study is to evaluate the accuracy of methylation analysis for sweat gland tumour classification with special emphasis on the distinction between DPA and mimickers. Methods and results Twelve DPA, 11 tubular adenomas, 12 hidradenomas, 8 apocrine and 6 eccrine mixed tumours, 7 poromas and 6 adnexal sweat gland carcinoma not otherwise specified (NOS) were submitted for DNA methylation profiling. The results of this analysis show that most of these tumour types formed their own unique cluster, setting them apart from the others. In particular, DPA cases clustered together and were distinct from other tumour entities including tubular adenomas.
Conclusions
Our data support the distinction between DPA and tubular adenomas as two unique entities and further confirm DNA methylation profiling as a relevant tool for tumour classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, AP-HP, Centre-Université Paris Cité, Paris, France.
- Caraderm Network, Lille, France.
- Department of Pathology, Timone University Hospital, Marseille, France.
- Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
- Department of Pathology, APHP Hôpital Saint Louis, Université Paris Cité, Paris, France.
ORCID-Profile: Pierre Sohier, Nicolas Macagno, Anne Tallet, Coralie Mousset, Maxime Battistella, Eduardo Calonje, Andreas Von Deimling, Thibault Kervarrec
Förderung
- illumina grant
Zitieren
APA
Sohier, P., Macagno, N., Tallet, A., Mousset, C., Battistella, M., Calonje, E., Von Deimling, A., & Kervarrec, T. (2025). Methylation analysis as a diagnostic tool for sweat gland tumours classification with emphasis on the distinction between digital papillary adenocarcinoma and mimickers. Histopathology. https://doi.org/10.1111/his.15479
Vancouver
Sohier P, Macagno N, Tallet A, Mousset C, Battistella M, Calonje E, et al. Methylation analysis as a diagnostic tool for sweat gland tumours classification with emphasis on the distinction between digital papillary adenocarcinoma and mimickers. Histopathology. 2025. doi:10.1111/his.15479
BibTeX
@article{Sohier2025,
author = {Sohier, Pierre and Macagno, Nicolas and Tallet, Anne and Mousset, Coralie and Battistella, Maxime and Calonje, Eduardo and Von Deimling, Andreas and Kervarrec, Thibault},
title = {Methylation analysis as a diagnostic tool for sweat gland tumours classification with emphasis on the distinction between digital papillary adenocarcinoma and mimickers},
journal = {Histopathology},
year = {2025},
doi = {10.1111/his.15479}
}
EUVIMED